Sphaeropsidin A C15–C16 Cross‐Metathesis Analogues with Potent Anticancer Activity
ChemMedChem · 2024
DOI: 10.1002/cmdc.202400288 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Sachin B Wagh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, Texas State University, San Marcos, Texas, 78666, USA. Hauptthemen laut MEDLINE: Antineoplastic Agents, Drug Screening Assays, Antitumor. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Research Foundation, South Africa, Denise M. Trauth Endowed Presidential Research Professorship, Stellenbosch University.
Abstract (Originalsprache)
We recently discovered that sphaeropsidin A (SphA), a fungal metabolite from Diplodia cupressi , overcomes apoptosis resistance in cancer cells by inducing cellular shrinkage by impairing regulatory volume increase. Previously, we prepared a pyrene‐conjugated derivative of SphA by a cross‐metathesis reaction involving the phytotoxin's C15,C16‐alkene. This derivative's evaluation in a cancer cell panel revealed a significant increase in potency, with the IC 50 values 5–10× lower than those displayed by the original natural product. Herein, we describe the preparation and anticancer evaluation of fifteen novel C15,C16‐alkene cross‐metathesis analogues in which the pyrene moiety was replaced with other aromatic or non‐aromatic hydrophobic groups. The idea for this replacement was to prepare a family of compounds that would not be predicted to be mutagenic compared with the original pyrene analogue. We predict several of our new compounds to be non‐mutagenic, while retaining the high potency of the original pyrene‐containing analogues. Examples of these potential lead compounds included those containing pentamethylphenyl and triphenylethylene pendant groups. As an additional feature of the current investigation, we prepared several deuterated pyrene‐containing compounds to overcome intellectual property issues associated with non‐patentability of the original pyrene derivative.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, Texas State University, San Marcos, Texas, 78666, USA.
- Department of Chemistry and Polymer Sciences, Stellenbosch University, Stellenbosch, Matieland, 7602, Western Cape, South Africa.
- Sciensano, Rue Juliette Wytsmanstraat 14, 1050, Brussels, Belgium.
- Institute of Sciences of Food Production, National Research Council, Via Amendola 122/O, 70125, Bari, Italy.
- Department of Pharmacotherapy and Pharmaceutics, Chemistry and Biochemistry, Faculté de Pharmacie, Université Libre de Bruxelles, Brussels, Belgium.
- ULB Cancer Research Center, U-CRC, Université Libre de Bruxelles, Brussels, Belgium.
ORCID-Profile: Dino Berthold, Willem A L van Otterlo, Alexander Kornienko
Förderung
- National Research Foundation, South Africa
- Denise M. Trauth Endowed Presidential Research Professorship
- Stellenbosch University
- NCI NIH HHS
- US National Institutes of Health
- Alexander von Humboldt Foundation
- National Institutes of Health
- Alexander von Humboldt-Stiftung
Zitieren
APA
Wagh, S. B., Berthold, D., Majeed, I., Lewis, L. K., Schilter, D., Mertens, B., Evidente, A., van Otterlo, W. A. L., Mathieu, V., & Kornienko, A. (2024). Sphaeropsidin A C15–C16 Cross‐Metathesis Analogues with Potent Anticancer Activity. ChemMedChem. https://doi.org/10.1002/cmdc.202400288
Vancouver
Wagh SB, Berthold D, Majeed I, Lewis LK, Schilter D, Mertens B, et al. Sphaeropsidin A C15–C16 Cross‐Metathesis Analogues with Potent Anticancer Activity. ChemMedChem. 2024. doi:10.1002/cmdc.202400288
BibTeX
@article{Wagh2024,
author = {Wagh, Sachin B and Berthold, Dino and Majeed, Iram and Lewis, L Kevin and Schilter, David and Mertens, Birgit and Evidente, Antonio and van Otterlo, Willem A L and Mathieu, Véronique and Kornienko, Alexander},
title = {Sphaeropsidin A C15–C16 Cross‐Metathesis Analogues with Potent Anticancer Activity},
journal = {ChemMedChem},
year = {2024},
doi = {10.1002/cmdc.202400288}
}
EUVIMED